Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Inventor:
Brekau; Uwe
Address:
Cologne, DE
No. of patents:
2
Patents:












Patent Number Title Of Patent Date Issued
5964693 Continuous preparation of silica sols which contain large particles October 12, 1999
A process is provided for the preparation of aqueous silica sols having a particle size of 27 to 72 nm. by adding fresh acidic silica sol into the reactors of a multi stage cascade reactor wherein the reactors contain aqueous solution of colloidal silica sol of a pH of 8 or above. Each
5458812 Process for the production and concentration of silica sols October 17, 1995
Process for the production and concentration of alkaline silica sols containing nonaggregated, spherical SiO.sub.2 particles with a diameter of .gtoreq.1 nm starting with SiO.sub.2 concentrations of 4-8% by weight, using microporous membrane filters.










 
 
  Recently Added Patents
Methods and apparatus for achieving multiple bit rates in passive optical networks
Wireless communication system, wireless communication device, wireless communication method, and program
Wireless communication power control
Antimicrobial polysiloxane materials containing metal species
Kit and method for the capture of tumor cells
Test method for inspection device, particularly for label seating inspection device
Audio conversation apparatus
  Randomly Featured Patents
Differential driver having multiple output voltage ranges
Device for locating mass centers and other purposes
Method for applying solder to and mounting components on printed circuit boards
Heat-exchanger assembly with wedge-shaped tubes with balanced coolant flow
Network video guide and spidering
Method of obtaining conformational polymorph of sucrose
Device with anti-counterfeiting diffractive structure
Apparatus for weather prediction
System and method for extending a programming language to include multiple dissimilar object systems
Process for purifying N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide (zaleplon) and crystalline forms of zaleplon accessible with the process